A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells

Nature Medicine

Volumn 12, Issue 4, 2006, Pages 410-416

  Lee, Ju Seog ^a   Heo, Jeonghoon ^a   Libbrecht, Louis ^b   Chu, In Sun ^c   Kaposi Novak, Pal ^a   Calvisi, Diego F ^a   Mikaelyan, Arsen ^a   Roberts, Lewis R ^d   Demetris, Anthony J ^e   Sun, Zongtang ^f   Nevens, Frederik ^b   Roskams, Tania ^b   Thorgeirsson, Snorri S ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF LEUVEN   (Belgium)

^c Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^d MAYO CLINIC   (United States)

^e UNIVERSITY OF PITTSBURGH   (United States)

^f CANCER HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER INVASION; CARCINOGENESIS; CELL PROLIFERATION; CONTROLLED STUDY; EMBRYO; FEMALE; FETUS; FETUS CELL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CELL; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MOUSE; NONHUMAN; PHENOTYPE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RAT; STEM CELL;

AGED; ANIMALS; APOPTOSIS; CARCINOMA, HEPATOCELLULAR; CELL PROLIFERATION; CHINA; CLUSTER ANALYSIS; COHORT STUDIES; DNA, NEOPLASM; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, NEOPLASM; HEPATOCYTES; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER NEOPLASMS; MALE; MICE; MODELS, BIOLOGICAL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGNOSIS; RATS; REPRODUCIBILITY OF RESULTS; STEM CELLS; SURVIVAL ANALYSIS;

ANIMALIA;

EID: 33645742425     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm1377     Document Type: Article

References (40)

1. Parkin, D.M., Bray, F., Ferlay, J. & Pisani, P. Estimating the world cancer burden: Globocan 2000. Int. J. Cancer 94, 153-156 (2001).
2. El Serag, H.B. & Mason, A.C. Rising incidence of hepatocellular carcinoma in the United States. N. Engl. J. Med. 340, 745-750 (1999).
3. Bruix, J., Boix, L., Sala, M. & Llovet, J.M. Focus on hepatocellular carcinoma. Cancer Cell 5, 215-219 (2004).
4. Llovet, J.M. et al. Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials. Hepatology 29, 62-67 (1999).
5. Hanahan, D. & Weinberg, R.A. The hallmarks of cancer. Cell 100, 57-70 (2000).
6. Alizadeh, A.A. et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403, 503-511 (2000).
7. Ross, D.T. et al. Systematic variation in gene expression patterns in human cancer cell lines. Nat. Genet. 24, 227-235 (2000).
8. Roskams, T.A., Libbrecht, L. & Desmet, V.J. Progenitor cells in diseased human liver. Semin. Liver Dis. 23, 385-396 (2003).
9. Lee, J.S. et al. Application of comparative functional genomics to identify best-fit mouse models to study human cancer. Nat. Genet. 36, 1306-1311 (2004).
10. Lee, J.S., Grisham, J.W. & Thorgeirsson, S.S. Comparative functional genomics for identifying models of human cancer. Carcinogenesis 26, 1013-1020 (2005).
11. Petkov, P.M. et al. Gene expression pattern in hepatic stem/progenitor cells during rat fetal development using complementary DNA microarrays. Hepatology 39, 617-627 (2004).
12. Dabeva, M.D. & Shafritz, D.A. Hepatic stem cells and liver repopulation. Semin. Liver Dis. 23, 349-362 (2003).
13. Thorgeirsson, S.S. & Grisham, J.W. Overview of recent experimental studies on liver stem cells. Semin. Liver Dis. 23, 303-312 (2003).
14. Lee, J.S. et al. Classification and prediction of survival in hepatocellular carcinoma by gene expression profiling. Hepatology 40, 667-676 (2004).
15. Chambers, A.F. & Matrisian, L.M. Changing views of the role of matrix metalloproteinases in metastasis. J. Natl. Cancer Inst. 89, 1260-1270 (1997).
16. Andreasen, P.A., Egelund, R. & Petersen, H.H. The plasminogen activation system in tumor growth, invasion, and metastasis. Cell. Mol. Life Sci. 57, 25-40 (2000).
17. Chang, C. & Werb, Z. The many faces of metalloproteases: cell growth, invasion, angiogenesis and metastasis. Trends Cell Biol. 11, S37-S43 (2001).
18. Jothy, S. CD44 and its partners in metastasis. Clin. Exp. Metastasis 20, 195-201 (2003).
19. Yu, Y. et al. Expression profiling identifies the cytoskeletal organizer ezrin and the developmental homeoprotein Six-1 as key metastatic regulators. Nat. Med. 10, 175-181 (2004).
20. Khanna, C. et al. The membrane-cytoskeleton linker ezrin is necessary for osteosarcoma metastasis. Nat. Med. 10, 182-186 (2004).
21. Curto, M. & McClatchey, A.I. Ezrin.a metastatic detERMinant? Cancer Cell 5, 113-114 (2004).
22. Martin, T.A., Harrison, G., Mansel, R.E. & Jiang, W.G. The role of the CD44/ezrin complex in cancer metastasis. Crit. Rev. Oncol. Hematol. 46, 165-186 (2003).
23. Kondo, K. et al. Risk factors for early death after liver resection in patients with solitary hepatocellular carcinoma. J. Hepatobiliary Pancreat. Surg. 12, 399-404 (2005).
24. Gouillat, C., Manganas, D., Saguier, G., Duque-Campos, R. & Berard, P. Resection of hepatocellular carcinoma in cirrhotic patients: longterm results of a prospective study. J. Am. Coll. Surg. 189, 282-290 (1999).
25. Lee, J.S. & Thorgeirsson, S.S. Genome-scale profiling of gene expression in hepatocellular carcinoma: classification, survival prediction, and identification of therapeutic targets. Gastroenterology 127, S51-S55 (2004).
26. Kitano, H. Cancer robustness: tumour tactics. Nature 426, 125 (2003).
27. Postic, C. & Magnuson, M.A. DNA excision in liver by an albumin-Cre transgene occurs progressively with age. Genesis 26, 149-150 (2000).
28. Pinkert, C.A., Ornitz, D.M., Brinster, R.L. & Palmiter, R.D. An albumin enhancer located 10 kb upstream functions along with its promoter to direct efficient, liver-specific expression in transgenic mice. Genes Dev. 1, 268-276 (1987).
29. Huh, C.G. et al. Hepatocyte growth factor/c-met signaling pathway is required for efficient liver regeneration and repair. Proc. Natl. Acad. Sci. USA 101, 4477-4482 (2004).
30. Ferrando, A.A. et al. Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia. Cancer Cell 1, 75-87 (2002).
31. Sarraf, C. et al. Cell behavior in the acetylaminofluorene-treated regenerating rat liver. Light and electron microscopic observations. Am. J. Pathol. 145, 1114-1126 (1994).
32. Eferl, R. et al. Liver tumor development. c-Jun antagonizes the proapoptotic activity of p53. Cell 112, 181-192 (2003).
33. Hilberg, F., Aguzzi, A., Howells, N. & Wagner, E.F. c-jun is essential for normal mouse development and hepatogenesis. Nature 365, 179-181 (1993).
34. Logan, C.Y. & Nusse, R. The Wnt signaling pathway in development and disease. Annu. Rev. Cell Dev. Biol. 20, 781-810 (2004).
35. Lee, J.S. & Thorgeirsson, S.S. Genetic profiling of human hepatocellular carcinoma. Semin. Liver Dis. 25, 125-132 (2005).
36. Robrechts, C. et al. Primary liver tumour of intermediate (hepatocyte-bile duct cell) phenotype: a progenitor cell tumour? Liver 18, 288-293 (1998).
37. Libbrecht, L., Desmet, V., Van Damme, B. & Roskams, T. The immunohistochemical phenotype of dysplastic foci in human liver: correlation with putative progenitor cells. J. Hepatol. 33, 76-84 (2000).
38. Wu, P.C. et al. Classification of hepatocellular carcinoma according to hepatocellular and biliary differentiation markers. Clinical and biological implications. Am. J. Pathol. 149, 1167-1175 (1996).
39. Uenishi, T. et al. Cytokeratin 19 expression in hepatocellular carcinoma predicts early postoperative recurrence. Cancer Sci. 94, 851-857 (2003).
40. Durnez, A. et al. The clinicopathological and prognostic relevance of cytokeratin 7 and 19 expression in hepatocellular carcinoma. Hepatology (in the press).